UCB SA (UCBJF)
304.84
-0.75
(-0.25%)
USD |
OTCM |
Oct 27, 16:00
UCB Market Cap : 58.12B for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 58.12B |
| October 26, 2026 | 58.26B |
| October 23, 2026 | 55.94B |
| October 22, 2026 | 56.69B |
| October 21, 2026 | 47.73B |
| October 20, 2026 | 45.35B |
| October 19, 2026 | 45.35B |
| October 16, 2026 | 45.60B |
| October 15, 2026 | 45.80B |
| October 14, 2026 | 44.98B |
| October 13, 2026 | 44.98B |
| October 12, 2026 | 45.45B |
| October 09, 2026 | 44.35B |
| October 08, 2026 | 45.12B |
| October 07, 2026 | 45.18B |
| October 06, 2026 | 45.18B |
| October 05, 2026 | 44.89B |
| October 02, 2026 | 45.48B |
| October 01, 2026 | 44.51B |
| September 30, 2026 | 47.03B |
| September 29, 2026 | 47.03B |
| September 28, 2026 | 46.92B |
| September 25, 2026 | 44.93B |
| September 24, 2026 | 46.50B |
| September 23, 2026 | 45.09B |
| Date | Value |
|---|---|
| September 22, 2026 | 45.09B |
| September 21, 2026 | 44.59B |
| September 18, 2026 | 47.76B |
| September 17, 2026 | 47.12B |
| September 16, 2026 | 47.31B |
| September 15, 2026 | 47.78B |
| September 14, 2026 | 48.06B |
| September 11, 2026 | 46.93B |
| September 10, 2026 | 44.19B |
| September 09, 2026 | 46.99B |
| September 08, 2026 | 47.92B |
| September 04, 2026 | 48.68B |
| September 03, 2026 | 47.40B |
| September 02, 2026 | 50.35B |
| September 01, 2026 | 48.08B |
| August 31, 2026 | 47.83B |
| August 28, 2026 | 47.83B |
| August 27, 2026 | 51.02B |
| August 26, 2026 | 50.83B |
| August 25, 2026 | 50.97B |
| August 24, 2026 | 50.97B |
| August 21, 2026 | 50.16B |
| August 20, 2026 | 49.40B |
| August 19, 2026 | 49.83B |
| August 18, 2026 | 48.54B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 652.35B |
| Eli Lilly & Co. | 1.214T |
| Novo Nordisk A/S | 128.08B |
| Pfizer Inc. | 167.98B |
| Teva Pharmaceutical Industries Ltd. | 46.57B |
Market Cap Related Metrics
| PE Ratio | 23.12 |
| PS Ratio | 5.950 |
| PEG Ratio | 0.0258 |
| Price to Free Cash Flow | 42.03 |
| Price | 304.84 |
| Earnings Yield | 4.33% |
| PEGY Ratio | 0.0258 |
| Operating PE Ratio | 18.69 |
| Normalized PE Ratio | 22.92 |